<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Novoheart expands global presence to support comme...

Key learnings: Novoheart has developed human bioengineered heart constructs...

Read More

Zilico’s diagnostic device moves towards Chinese a...

Key learnings: UK-based Zilico has entered into a strategic deal with MaxHe...

Read More

Interview with Race Oncology’s Peter Molloy

Peter Molloy, Chief Executive Officer at ASX-listed Race Oncology, talks th...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent inve...

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

WideCells sets course for synergistic growth

Key learnings: WideCells Group has achieved some significant milestones thi...

Read More

Global therapeutic IPO market: Q3 2017 analysis

The global therapeutic IPO market has failed to maintain the upward momentu...

Read More

How will China’s Cybersecurity Law impact the life...

Key learnings: The Cybersecurity Law came into effect in China’s territorie...

Read More

Add Your Response